Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03102262

Ligand	Ligand name	Chain	PDB	Tanimoto
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.75
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.76
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.74
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.78
TG1		A,B	2AGV	0.7
TG1		A	2ZBF	0.7
TG1		A	2ZBG	0.7
TG1		A,B,C,D	1WPG	0.7
TG1		A	2C8L	0.7
TG1		A	2EAR	0.7
TG1		A,B	1IWO	0.7
TG1		A	2C88	0.7
TG1		A	2DQS	0.7
TG1		A	2C8K	0.7
TG1		A	1XP5	0.7
TG1		A	2EAT	0.7
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.71
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.87
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.72
E2P	PROSTAGLANDIN B2	A	1CZ2	0.71
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.75
FUA	FUSIDIC ACID	A	1QCA	0.74
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.74
FUA	FUSIDIC ACID	A,B	2VUF	0.74
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.72
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.72
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.72
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.81
SRN	SORANGICIN A	C,D	1YNJ	0.7
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.73
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDS	0.7
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDN	0.7
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.86
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.86
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.71
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.79
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.79
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.79
MRC	MUPIROCIN	A	1JZS	0.72
MRC	MUPIROCIN	A,T	1FFY	0.72
MRC	MUPIROCIN	A	1QU3	0.72
MRC	MUPIROCIN	A,T	1QU2	0.72
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.71
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.86
RGC	REIDISPONGIOLIDE C	A	2ASP	0.76
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.71